EUVIMEDEUVIMED entdecken
Open Access

Racial and Ethnic Differences in County-Level Availability of Uterine Cancer Clinical Trials

Ashley S Felix, Caitlin E Meade, Jeffrey J Wing, Simran A Kanal, Laura M Chambers, Britton Trabert, Jennifer A Sinnott

JAMA Network Open · 13.11.2026 · 9 (11) · e2644045

DOI: 10.1001/jamanetworkopen.2026.44045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 13.11.2026. Verfasst von Ashley S Felix und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Caroli…. Hauptthemen laut MEDLINE: Uterine Neoplasms, Clinical Trials as Topic, Healthcare Disparities, Ethnicity. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Racial and ethnic disparities exist in clinical trial enrollment, but whether such disparities exist in geographic availability of uterine cancer trials is unknown.

Objective

To examine associations between race and ethnicity and county-level presence and rates of available uterine cancer clinical trials. Design, Setting, and Participants This retrospective cohort study linked Surveillance, Epidemiology, and End Results Research Plus; Aggregate Analysis of ClinicalTrials.gov; and American Community Survey data of adult patients (aged ≥18 years) diagnosed with uterine cancer between January 1, 2008, and December 31, 2021. The data analysis was performed between November 10, 2025, and September 9, 2026. Exposures Race and ethnicity categorized as American Indian or Alaska Native, Asian, Black, Hispanic (any race), Native Hawaiian or Pacific Islander, and White. Main Outcomes and Measures The main outcomes were county-level presence and rate of interventional uterine cancer trials. Hurdle models were used to estimate racial and ethnic differences in the odds of residing in a county with at least 1 trial and among patients in counties with trial availability, differences in rates of trials per person. Models accounted for county clustering and were adjusted for patient characteristics.

Results

Among 155 811 patients in the cohort (median [IQR] age at diagnosis, 62 [55-69] years; 1055 identifying as American Indian or Alaska Native [0.7%], 12 753 as Asian [8.2%], 16 303 as Black [10.5%], 23 177 as Hispanic [14.9%], 2175 as Native Hawaiian or Pacific Islander [1.4%], and 100 348 as White [64.4%] race and ethnicity), 121 525 (78.0%) resided in a county with at least 1 available trial. Trial availability was observed among 58.0% of American Indian or Alaska Native patients, 94.3% of Asian patients, 77.7% of Black patients, 86.1% of Hispanic patients, 90.3% of Native Hawaiian or Pacific Islander patients, and 74.1% of White patients. Compared with White patients, higher odds of residing in counties with at least 1 available trial were found for Asian (odds ratio [OR], 5.83; 95% CI, 4.83-7.12), Black (OR, 1.18; 95% CI, 1.07-1.30), Hispanic (OR, 2.18; 95% CI, 1.80-2.63), and Native Hawaiian or Pacific Islander (OR, 3.34; 95% CI, 2.17-5.66) patients, whereas American Indian or Alaska Native patients had lower odds (OR, 0.49; 95% CI, 0.39-0.61). Among patients in counties with at least 1 trial, fewer available trials per person were found for Asian (rate ratio [RR], 0.69; 95% CI, 0.65-0.74), Hispanic (RR, 0.56; 95% CI, 0.52-0.61), and Native Hawaiian or Pacific Islander (RR, 0.87; 95% CI, 0.80-0.95) patients compared with White patients. Conclusions and Relevance This cohort study of patients with uterine cancer found that racial and ethnic patterns in geographic trial availability differed by how availability was measured. The presence of any trial may not fully capture geographic access to clinical trial opportunities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine NeoplasmsClinical Trials as TopicHealthcare DisparitiesEthnicityRacial GroupsHealth Services AccessibilityHumansFemaleRetrospective StudiesMiddle AgedSEER ProgramAgedUnited StatesHispanic or LatinoWhiteAdult

Autor:innen und Institutionen

  • Division of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Division of Epidemiology, College of Public Health, The Ohio State University, Columbus.
  • Division of Gynecologic Oncology, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus.
  • Department of Obstetrics and Gynecology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.
  • Huntsman Cancer Institute, University of Utah, Salt Lake City.
  • Department of Statistics, College of Arts and Sciences, The Ohio State University, Columbus.

Zitieren

APA

Felix, A. S., Meade, C. E., Wing, J. J., Kanal, S. A., Chambers, L. M., Trabert, B., & Sinnott, J. A. (2026). Racial and Ethnic Differences in County-Level Availability of Uterine Cancer Clinical Trials. JAMA Network Open, 9(11), e2644045. https://doi.org/10.1001/jamanetworkopen.2026.44045

Vancouver

Felix AS, Meade CE, Wing JJ, Kanal SA, Chambers LM, Trabert B, et al. Racial and Ethnic Differences in County-Level Availability of Uterine Cancer Clinical Trials. JAMA Network Open. 2026;9(11):e2644045. doi:10.1001/jamanetworkopen.2026.44045

BibTeX
@article{Felix2026,
  author = {Felix, Ashley S and Meade, Caitlin E and Wing, Jeffrey J and Kanal, Simran A and Chambers, Laura M and Trabert, Britton and Sinnott, Jennifer A},
  title = {Racial and Ethnic Differences in County-Level Availability of Uterine Cancer Clinical Trials},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {11},
  pages = {e2644045},
  doi = {10.1001/jamanetworkopen.2026.44045}
}
Kostenlos starten →